Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine (Q27732560)

1

0 references

T N Bhat

2

0 references

S Gulnik

3

0 references

B Liu

4

0 references

I A Topol

5

0 references

Y Kiso

6

0 references

T Mimoto

7

0 references

H Mitsuya

8

0 references

J W Erickson

The HIV-1 protease as a therapeutic target for AIDS

9

0 references

publication date

15 June 1995

0 references

published in

Structure

0 references

volume

3

0 references

page(s)

581-90

0 references

issue

6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

HIV protease: a novel chemotherapeutic target for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Kynostatin (KNI)-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Crystal structure of a complex of HIV‐1 protease with a dihydroxyethylene‐containing inhibitor: Comparisons with molecular modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Determinants of repressor/operator recognition from the structure of the trp operator binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Bound water molecules and conformational stabilization help mediate an antigen-antibody association

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900192-7

7 January 2021